Since LPA mediates its effects via GPCRs to activate multiple intracellular signaling pathways including AKT/mTOR [11, 12], we next assessed whether addition of LPA alters the AKT/mTOR pathway in a malignant renal tumor cell line. The gene discussed is MTOR; the disease is kidney neoplasm.